Home / Flokind-D Tablet
Flokind-D Tablet

Flokind-D Tablet

(0 customer reviews)

$0.53 / unit

Available Options

Pack SizePricePrice / UnitQuantityAction
180 Tablets$71.00$0.39/unit
150 Tablets$61.00$0.41/unit
120 Tablets$50.00$0.42/unit
90 Tablets$40.00$0.44/unit
60 Tablets$28.00$0.47/unit
30 Tablets$16.00$0.53/unit
Looking for bulk / B2B pricing?

Product Description

FLOKIND-D TABLET

Brand Name: Flokind-D Tablet
Generic Name: Tamsulosin Hydrochloride + Dutasteride
Strength: Tamsulosin Hydrochloride 0.4 mg + Dutasteride 0.5 mg
Dosage Form: Oral Tablet
Therapeutic Class: Alpha-1 Adrenergic Blocker + 5-Alpha Reductase Inhibitor / Benign Prostatic Hyperplasia Medicine
Manufacturer / Marketer: Mankind Pharma Ltd.
Pack Size: 1 × 10 Tablets

What is this medicine?

FLOKIND-D TABLET contains Tamsulosin Hydrochloride 0.4 mg and Dutasteride 0.5 mg, a combination medicine used to treat symptoms of benign prostatic hyperplasia (BPH) in adult men.

Benign prostatic hyperplasia is a noncancerous enlargement of the prostate gland.

The prostate is a small gland located below the urinary bladder and surrounds part of the urethra, the tube that carries urine out of the body.

As men age, the prostate may gradually increase in size. This can place pressure on the urethra and interfere with the normal flow of urine.

Common symptoms include:

  • Difficulty starting urination

  • Weak urinary stream

  • Frequent urination

  • Urgent need to urinate

  • Waking repeatedly at night to urinate

  • Interrupted urine flow

  • Straining during urination

  • Difficulty emptying the bladder completely

  • A sensation of incomplete bladder emptying

Flokind-D combines two medicines with complementary mechanisms.

Tamsulosin helps relax smooth muscles around the prostate and bladder neck, while dutasteride gradually reduces the hormonal stimulation responsible for prostate enlargement.

How Does Flokind-D Work?

Tamsulosin Hydrochloride 0.4 mg

Tamsulosin belongs to a group of medicines called alpha-1 adrenergic blockers.

It selectively blocks certain alpha-1 adrenergic receptors in the prostate and bladder neck.

This helps:

  • Relax smooth muscle

  • Reduce resistance to urine flow

  • Improve urinary stream

  • Reduce difficulty starting urination

  • Improve certain lower urinary tract symptoms

Tamsulosin may begin improving symptoms within days to weeks, although individual responses vary.

Dutasteride 0.5 mg

Dutasteride belongs to a group of medicines called 5-alpha reductase inhibitors.

It blocks the type I and type II 5-alpha reductase enzymes, which convert testosterone into dihydrotestosterone (DHT).

DHT contributes to prostate growth.

By reducing DHT levels, dutasteride may:

  • Gradually reduce prostate size

  • Improve urinary symptoms over time

  • Reduce the risk of acute urinary retention

  • Lower the likelihood of BPH-related surgery

  • Slow the progression of symptomatic prostate enlargement

Dutasteride generally requires several months before its full effects become apparent.

Common Uses

Flokind-D Tablet may be prescribed for:

  • Benign prostatic hyperplasia (BPH)

  • Symptomatic enlargement of the prostate

  • Weak urinary flow associated with BPH

  • Difficulty starting urination

  • Frequent urination

  • Urinary urgency

  • Nighttime urination caused by BPH

  • Difficulty emptying the bladder

  • Management of moderate to severe lower urinary tract symptoms

  • Long-term treatment of enlarged prostate when combination therapy is appropriate

Important Treatment Consideration

Flokind-D is not intended to treat prostate cancer.

It also does not treat bacterial urinary tract infections, sexually transmitted infections or every possible cause of urinary difficulty.

Patients with persistent urinary symptoms should undergo appropriate prostate and urinary tract evaluation.

NOTE: Flokind-D Tablet contains tamsulosin and dutasteride. It is different from Flokind 0.4 Tablet, which contains tamsulosin alone, and Flokind-F, which contains a different 5-alpha reductase inhibitor combination.

What should I tell my healthcare provider before I take this medicine?

Inform your healthcare provider if you have:

  • Allergy to tamsulosin

  • Allergy to dutasteride

  • Previous reactions to other alpha-blockers

  • Previous reactions to 5-alpha reductase inhibitors

  • Low blood pressure

  • Orthostatic hypotension

  • Frequent dizziness

  • Previous fainting episodes

  • Heart disease

  • Liver disease

  • Severe liver impairment

  • Kidney disease

  • Prostate cancer or suspected prostate cancer

  • Abnormal prostate-specific antigen (PSA) levels

  • Blood in the urine

  • Recurrent urinary tract infections

  • Bladder stones

  • Severe urinary retention

  • Difficulty emptying the bladder completely

  • Cataracts

  • Planned cataract surgery

  • Planned glaucoma surgery

  • Erectile dysfunction

  • Reduced sexual desire

  • Ejaculation difficulties

  • Fertility concerns

  • Breast lumps or breast tenderness

  • Depression

  • Significant mood changes

  • Use of blood pressure medicines

  • Use of erectile dysfunction medicines

  • Use of other prostate medicines

Tell your healthcare provider about all prescription medicines, nonprescription medicines, vitamins, supplements and herbal preparations you currently use.

Important Contraindications

The combination should not be used in patients with:

  • Known serious hypersensitivity to tamsulosin or dutasteride

  • Serious hypersensitivity to related 5-alpha reductase inhibitors

  • Allergy to another ingredient in the product

The dutasteride component is contraindicated during pregnancy.

Flokind-D is not intended for women or children.

Important Low Blood Pressure Warning

Tamsulosin may lower blood pressure, especially when standing up.

This can cause:

  • Dizziness

  • Light-headedness

  • Weakness

  • Blurred vision

  • Fainting

The risk may be higher when starting treatment or when restarting after an interruption.

Important: Rise slowly from sitting or lying positions, particularly during the initial treatment period.

Important Pregnancy Warning

Dutasteride can interfere with the development of external genitalia in a male fetus.

Women who are pregnant or may become pregnant should avoid handling leaking or damaged dutasteride-containing products.

If contact with leaked material occurs, the affected area should be washed promptly with soap and water.

Important: Flokind-D is not intended for use during pregnancy.

How should I use this medicine?

Take Flokind-D Tablet exactly as prescribed by your healthcare provider.

  • Swallow the tablet whole with water.

  • Take it once daily as prescribed.

  • Take it at approximately the same time each day.

  • Follow the meal-related instructions on your product packaging.

  • Do not crush, split or chew the tablet unless specifically permitted by the manufacturer.

  • Do not exceed the prescribed dose.

  • Do not take additional alpha-blockers without medical advice.

  • Avoid standing up suddenly if you feel dizzy.

  • Monitor for changes in urinary symptoms.

  • Attend recommended prostate examinations.

  • Complete PSA tests as advised.

  • Report sexual side effects.

  • Inform your doctor about planned eye surgery.

  • Do not stop or change treatment without medical advice.

  • Do not share the medicine with another person.

Usual Adult Dosage

Flokind-D Composition: Tamsulosin Hydrochloride 0.4 mg + Dutasteride 0.5 mg.

Usual Adult Regimen: One tablet orally once daily, as prescribed.

Reference Combination Regimen: Established international prescribing information for the corresponding dutasteride–tamsulosin combination recommends one dose once daily, approximately 30 minutes after the same meal each day.

Important Formulation Note: The international reference product is a capsule, whereas Flokind-D is listed in India as a tablet. Follow the actual Flokind-D package instructions for administration.

Treatment Timing: Preferably at a consistent time every day.

Initial Symptom Response: Tamsulosin may improve some urinary symptoms within the first few weeks.

Long-Term Response: Dutasteride may require several months to reduce prostate size and provide its full benefit.

Treatment Review: The healthcare provider may assess symptoms and treatment response after several weeks and periodically thereafter.

Long-Term Use: Treatment may continue for months or years when clinically appropriate.

Kidney Impairment: Dose adjustment is not usually required for many patients, but severe renal impairment requires individualized assessment.

Liver Impairment: Use cautiously in liver disease. Significant hepatic impairment requires specialist evaluation because both ingredients may have increased exposure.

Older Adults: The combination is commonly prescribed to older men with symptomatic BPH, with attention to blood pressure and fall risk.

Children: Not indicated for pediatric use.

Women: Not indicated for use in women.

Overdosage: Seek immediate medical attention if excessive tablets are taken, particularly if dizziness, fainting or severe low blood pressure develops.

Important Dosage Considerations

Treatment selection depends on:

  • Prostate size

  • Severity of urinary symptoms

  • PSA results

  • Blood pressure

  • Liver and kidney function

  • Other medicines

  • Risk of urinary retention

  • Individual treatment response

NOTE: Taking more than the prescribed amount does not provide faster relief and may increase the risk of dangerous blood pressure changes and other adverse effects.

What if I miss a dose?

If you miss a dose:

  • Take it when remembered on the same day unless it is nearly time for the next scheduled dose.

  • If the next dose is approaching, skip the missed dose.

  • Continue with your regular schedule.

  • Do not take two tablets together.

  • Do not double the dose to compensate.

If you have stopped taking Flokind-D for several days, contact your healthcare provider before restarting because tamsulosin may cause dizziness or low blood pressure when treatment resumes.

Important: Do not take extra tablets to obtain immediate relief from urinary symptoms.

What may interact with this medicine?

Flokind-D may interact with medicines that affect blood pressure, tamsulosin metabolism, dutasteride exposure or urinary function.

Potential interactions include:

  • Ketoconazole

  • Itraconazole

  • Clarithromycin

  • Ritonavir

  • Other strong CYP3A4 inhibitors

  • Paroxetine

  • Fluoxetine

  • Other CYP2D6 inhibitors

  • Sildenafil

  • Tadalafil

  • Vardenafil

  • Other phosphodiesterase type 5 inhibitors

  • Doxazosin

  • Alfuzosin

  • Silodosin

  • Other alpha-blockers

  • Cimetidine

  • Warfarin

  • Other blood pressure medicines

  • Alcohol

Important Drug Interaction Considerations

Ketoconazole and Other Strong CYP3A4 Inhibitors: Can significantly increase tamsulosin exposure. Strong inhibitors should generally not be combined with this medicine.

Paroxetine: Can increase tamsulosin exposure through CYP2D6 inhibition.

Clarithromycin: May increase tamsulosin concentrations and the risk of adverse effects.

Sildenafil and Tadalafil: These medicines may lower blood pressure. Combining them with tamsulosin can increase the risk of dizziness, hypotension and fainting.

Other Alpha-Blockers: Combining multiple alpha-blockers can increase low blood pressure risk and is generally avoided.

Cimetidine: May increase tamsulosin exposure.

Warfarin: Requires caution and clinical review because of potential effects on tamsulosin disposition.

Other Blood Pressure Medicines: May contribute to dizziness or low blood pressure in susceptible patients.

Alcohol: Can increase dizziness and light-headedness.

Important: Inform your healthcare provider about all medicines used for erectile dysfunction, hypertension, prostate disorders or fungal infections before taking Flokind-D.

What should I watch for while using this medicine?

Seek urgent medical attention if you experience:

  • Complete inability to pass urine

  • Severe lower abdominal pain

  • Severe dizziness or fainting

  • Chest pain

  • Difficulty breathing

  • Swelling of the face, lips, tongue or throat

  • Severe allergic reactions

  • A prolonged, painful erection

  • Significant weakness with low blood pressure

  • Blood in the urine with concerning symptoms

  • Fever accompanied by urinary difficulties

While using Flokind-D:

  • Monitor urinary symptoms.

  • Attend regular prostate examinations.

  • Complete PSA testing when advised.

  • Check blood pressure when recommended.

  • Watch for dizziness on standing.

  • Report persistent sexual side effects.

  • Inform your doctor about breast tissue changes.

  • Discuss fertility concerns.

  • Tell your ophthalmologist about treatment before eye surgery.

  • Follow the prescribed daily schedule.

Important Monitoring Tests

Prostate-Specific Antigen (PSA): Helps evaluate prostate health. Dutasteride can lower PSA levels by approximately 50% after several months of treatment.

Digital Rectal Examination (DRE): May form part of the prostate assessment.

International Prostate Symptom Score (IPSS): Helps measure urinary symptom severity and response to treatment.

Urine Flow Testing: May help evaluate obstruction and improvements in urinary flow.

Post-Void Residual Volume: Measures urine remaining in the bladder after urination.

Blood Pressure: Particularly relevant when treatment begins or dizziness develops.

Kidney Function: May be assessed when urinary obstruction or other relevant medical conditions exist.

Important PSA Test Warning

Dutasteride can significantly lower PSA levels.

A lower PSA result does not exclude prostate cancer.

Any confirmed increase from the lowest PSA value recorded during treatment should be evaluated by a clinician.

Important: Tell the doctor performing prostate screening that you are taking Flokind-D.

Important Eye Surgery Warning

Tamsulosin is associated with intraoperative floppy iris syndrome (IFIS) during cataract or glaucoma surgery.

This can complicate the surgical procedure.

Inform your eye surgeon about current or previous tamsulosin use before undergoing eye surgery.

Do not independently stop the medicine before surgery without medical instructions.

Important Prostate Cancer Warning

Dutasteride is not approved for preventing prostate cancer.

Studies involving 5-alpha reductase inhibitors have reported an increased observed proportion of high-grade prostate cancers, although interpretation of these results is complex.

Prostate monitoring remains important during treatment.

What side effects may I notice from this medicine?

Side effects that should be reported immediately:

  • Severe allergic reactions

  • Angioedema

  • Severe low blood pressure

  • Fainting

  • Priapism

  • Significant chest symptoms

  • Severe dizziness causing collapse

  • Serious skin reactions

  • Sudden inability to urinate

  • Other serious or unexpected symptoms

Side effects that usually do not require immediate medical attention:

  • Dizziness

  • Light-headedness

  • Headache

  • Reduced sexual desire

  • Erectile dysfunction

  • Ejaculation disorders

  • Reduced semen volume

  • Breast tenderness

  • Mild breast enlargement

  • Temporary weakness

  • Nasal congestion

These side effects do not occur in every patient.

Some symptoms may improve as the body adjusts to treatment, while others may persist or require treatment reassessment.

Important Sexual Side Effect Warning

Flokind-D can affect sexual function.

Possible effects include:

  • Reduced libido

  • Erectile dysfunction

  • Difficulty ejaculating

  • Reduced ejaculate volume

  • Changes in semen parameters

Persistent sexual symptoms after discontinuing dutasteride have been reported.

Patients should discuss troublesome symptoms with their healthcare provider.

Important Priapism Warning

Tamsulosin can rarely cause priapism, a prolonged and painful erection.

An erection lasting more than four hours requires emergency medical treatment to prevent permanent tissue damage.

Important Fertility Consideration

Dutasteride may affect semen volume, sperm count and other semen parameters in some men.

Men planning conception should discuss the potential implications with their clinician.

Important Breast Changes Warning

Breast tenderness and enlargement may occur with dutasteride.

Report breast lumps, nipple discharge or persistent breast pain promptly.

Where should I keep my medicine?

  • Store below 30°C according to the current Indian pharmacy listing.

  • Keep out of the reach of children.

  • Store in a cool, dry place.

  • Protect from excessive heat.

  • Protect from moisture.

  • Protect from direct sunlight.

  • Keep tablets in their original packaging.

  • Do not use after the expiry date.

  • Do not use tablets from damaged or leaking packaging.

  • Keep away from pets.

  • Do not transfer tablets into unlabelled containers.

  • Dispose of expired or unused medicine according to pharmacist instructions.

Important Handling Precaution

Pregnant women or women who may become pregnant should avoid contact with leaking or damaged dutasteride-containing products.

Dutasteride can be absorbed through the skin.

Storage Note: Follow the exact instructions printed on the current Flokind-D strip or carton.

Manufacturer Details

Field

Information

Brand Name

Flokind-D Tablet

Generic Name

Tamsulosin Hydrochloride + Dutasteride

Tamsulosin Strength

0.4 mg

Dutasteride Strength

0.5 mg

Dosage Form

Oral Tablet

Therapeutic Class

Alpha-1 Adrenergic Blocker + 5-Alpha Reductase Inhibitor

Primary Indication

Benign Prostatic Hyperplasia (BPH)

Additional Clinical Benefits

Improvement in Urinary Flow and Reduction in BPH Progression

Manufacturer / Marketer

Mankind Pharma Ltd.

Actual Manufacturing Facility

Verify from Current Product Packaging

Prescription Status

Prescription Only Medicine

Route of Administration

Oral

Storage

Below 30°C; Follow Original Product Label

Pack Size

1 × 10 Tablets

Country of Origin

India

Last Updated on 02/11/2026

Medically Written ByDr. Marcus Vance, PharmDDr. Marcus Vance, PharmD

Last Updated on 02/11/2026

Medically Reviewed ByDr. Rachel Peter, PharmD, PhDDr. Rachel Peter, PharmD, PhD